Home › Funds › RA CAPITAL MANAGEMENT, L.P. › SION
RA CAPITAL MANAGEMENT, L.P. position in SION
SIONNA THERAPEUTICS INC · Health Care
RA CAPITAL MANAGEMENT, L.P. reported holding 9,905,045 shares of SION (SIONNA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$435.7M, representing 3.79% of its reported portfolio and ranking #5 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed SION holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How RA CAPITAL MANAGEMENT, L.P.'s SION position evolved
RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in SION in Q1 2025 at 10,445,322 shares (US$109.3M). The position peaked in Q2 2026 at 9,905,045 shares, worth US$435.7M. Across 6 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 9,905,045 shares valued at US$435.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 10.45M | $109.26M | New |
| Q2 2025 | 10.45M | $181.23M | Hold |
| Q3 2025 | 10.45M | $307.20M | Hold |
| Q4 2025 | 9.91M | $407.49M | Reduce |
| Q1 2026 | 9.91M | $397.09M | Hold |
| Q2 2026 | 9.91M | $435.72M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SION and 13F data
SION (SIONNA THERAPEUTICS INC) is a Health Care company. 86 other funds we track also report a position in SION — the largest reported positions include TPG GP A, LLC (US$285.7M), Atlas Venture Life Science Advisors, LLC (US$131.8M), ORBIMED ADVISORS LLC (US$112.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SION
- TPG GP A, LLC 6.49M sh · $285.71M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 3.00M sh · $131.78M · Q2 2026
- ORBIMED ADVISORS LLC 2.56M sh · $112.43M · Q2 2026
- Enavate Sciences GP, LLC 2.48M sh · $109.01M · Q2 2026
- PERCEPTIVE ADVISORS LLC 905.00K sh · $39.81M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 680.92K sh · $29.95M · Q2 2026
- Siren, L.L.C. 610.51K sh · $26.86M · Q2 2026
- Casdin Capital 400.00K sh · $17.60M · Q2 2026
- Kalehua Capital Management LLC 197.07K sh · $8.67M · Q2 2026
- Sofinnova Investments, Inc. 144.43K sh · $6.35M · Q2 2026
- GordonMD Global Investments LP 136.00K sh · $5.98M · Q2 2026
- Sio Capital Management, LLC 127.81K sh · $5.62M · Q2 2026
More on RA CAPITAL MANAGEMENT, L.P.
FAQ
How long has RA CAPITAL MANAGEMENT, L.P. held SION?
RA CAPITAL MANAGEMENT, L.P. has disclosed SION holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in SION?
As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 9.91M shares of SION (SIONNA THERAPEUTICS INC), valued at $435.72M, representing 3.79% of its reported portfolio and ranking #5.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling SION?
In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. held unchanged its position in SION. The position peaked in Q2 2026 at 9.91M shares.
Which other funds hold SION?
Other major institutional holders of SION include TPG GP A, LLC, Atlas Venture Life Science Advisors, LLC, ORBIMED ADVISORS LLC, among 86 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.